This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, S.-H. Articles by Hsu, H.-C. Search for Related Content PubMed PubMed Citation Articles by Liu, S.-H. Articles by Hsu, H.-C.

(American Journal of Pathology. 2002;160:1831-1837.)
© 2002 American Society for Investigative Pathology

Regular Articles

Down-Regulation of Annexin A10 in Hepatocellular Carcinoma Is Associated with Vascular Invasion, Early Recurrence, and Poor Prognosis in Synergy with p53 Mutation

Shu-Hsiang Liu^*, Chiao-Ying Lin, Shian-Yang Peng, Yung-Ming Jeng^*, Hung-Wei Pan^*, Po-Lin Lai^*, Chao-Lien Liu^* and Hey-Chi Hsu^*

From the Graduate Institutes of Pathology^*and Clinical Dentistry,College of Medicine, National Taiwan University, Taipei; and the Department of General Education,National Taipei College of Nursing, Taipei, Taiwan

Annexins (ANXs) are a large group of calcium-binding proteins participating in diverse important biological processes. ANXA10 is the least expressed new member of unknown function. We showed that ANXA10 mRNA was expressed in adult liver and hepatocellular carcinoma (HCC), but not in multiple adult and fetal tissues, cholangiocarcinoma, and several other common carcinomas. Of 182 unifocal primary HCCs, ANXA10 mRNA was dramatically reduced in 121 (66%), and the down-regulation correlated with p53 mutation (P = 0.024), early intrahepatic tumor recurrence (P = 0.0007), and lower 4-year survival (P = 0.0014). Down-regulation of ANXA10 was twofold more frequent in large than small HCCs (P = 0.0012), in grade II to III than grade I HCC (P < 0.00001), and in stage IIIA to IV than stage I to II HCC (P < 0.00001). Moreover, ANXA10 down-regulation and p53 mutation acted synergistically toward high-grade (P < 0.00001), high-stage HCC (P < 0.00001), and poorer prognosis (P = 0.0025). Our results indicate that the expression of the tissue- and tumor-restricted ANXA10 is a marker of liver cell differentiation and growth arrest, and its down-regulation associated with malignant phenotype of hepatocytes, vascular invasion, and progression of HCC, leading to poor prognosis. Thus, ANXA10 might serve as a new potential target of gene therapy for HCC.

This article has been cited by other articles:

				G. Nakato, S. Fukuda, K. Hase, R. Goitsuka, M. D. Cooper, and H. Ohno New Approach for M-Cell-Specific Molecules Screening by Comprehensive Transcriptome Analysis DNA Res, August 1, 2009; 16(4): 227 - 235. [Abstract] [Full Text] [PDF]

				S.-Y. Lin, H.-W. Pan, S.-H. Liu, Y.-M. Jeng, F.-C. Hu, S.-Y. Peng, P.-L. Lai, and H.-C. Hsu ASPM Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma Clin. Cancer Res., August 1, 2008; 14(15): 4814 - 4820. [Abstract] [Full Text] [PDF]

				R.-H. Yuan, Y.-M. Jeng, H.-W. Pan, F.-C. Hu, P.-L. Lai, P.-H. Lee, and H.-C. Hsu Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular Carcinoma Clin. Cancer Res., September 15, 2007; 13(18): 5368 - 5376. [Abstract] [Full Text] [PDF]

				C.-L. Liu, I-S. Yu, H.-W. Pan, S.-W. Lin, and H.-C. Hsu L2dtl Is Essential for Cell Survival and Nuclear Division in Early Mouse Embryonic Development J. Biol. Chem., January 12, 2007; 282(2): 1109 - 1118. [Abstract] [Full Text] [PDF]

				J. Earl, L. Yan, L. J. Vitone, J. Risk, S. J. Kemp, C. McFaul, J. P. Neoptolemos, W. Greenhalf, for the European Registry of Hereditary Pancreatit, R. Kress, et al. Evaluation of the 4q32-34 locus in European familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1948 - 1955. [Abstract] [Full Text] [PDF]

				Y.-C. Hsu, H.-H. Fu, Y.-M. Jeng, P.-H. Lee, and S.-D. Yang Proline-Directed Protein Kinase FA Is a Powerful and Independent Prognostic Predictor for Progression and Patient Survival of Hepatocellular Carcinoma J. Clin. Oncol., August 10, 2006; 24(23): 3780 - 3788. [Abstract] [Full Text] [PDF]

				R.-H. Yuan, Y.-M. Jeng, H.-L. Chen, F.-J. Hsieh, C.-Y. Yang, P.-H. Lee, and H.-C. Hsu Opposite Roles of Human Pancreatitis-Associated Protein and REG1A Expression in Hepatocellular Carcinoma: Association of Pancreatitis-Associated Protein Expression with Low-Stage Hepatocellular Carcinoma, {beta}-Catenin Mutation, and Favorable Prognosis Clin. Cancer Res., April 1, 2005; 11(7): 2568 - 2575. [Abstract] [Full Text] [PDF]

				Y.-M. Jeng, S.-Y. Peng, C.-Y. Lin, and H.-C. Hsu Overexpression and Amplification of Aurora-A in Hepatocellular Carcinoma Clin. Cancer Res., March 15, 2004; 10(6): 2065 - 2071. [Abstract] [Full Text] [PDF]

				J. M. Garcia Pedrero, M. P. Fernandez, R. O. Morgan, A. Herrero Zapatero, M. V. Gonzalez, C. Suarez Nieto, and J. P. Rodrigo Annexin A1 Down-Regulation in Head and Neck Cancer Is Associated with Epithelial Differentiation Status Am. J. Pathol., January 1, 2004; 164(1): 73 - 79. [Abstract] [Full Text] [PDF]

				J. Kirshner, D. Schumann, and J. E. Shively CEACAM1, a Cell-Cell Adhesion Molecule, Directly Associates with Annexin II in a Three-dimensional Model of Mammary Morphogenesis J. Biol. Chem., December 12, 2003; 278(50): 50338 - 50345. [Abstract] [Full Text] [PDF]